GridAI Technologies (GRDX) Intangibles (2015 - 2026)

GridAI Technologies' (GRDX) quarterly Intangibles came in at $20.7 million in Q2 2026, down 5.26% quarter-over-quarter from $21.8 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Intangibles (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Intangibles for 10 consecutive years, with $20.7 million the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Intangibles changed N/A year-over-year to $20.7 million; the trailing twelve-month figure through Jun 2026 stood at $20.7 million (changed N/A YoY), and the FY2025 full-year result was $21.8 million, changed N/A from the prior year.
Intangibles slipped to $20.7 million in Q2 2026 per GRDX's latest filing, from $21.8 million in the prior quarter.
Across five years, Intangibles topped out at $21.8 million in Q4 2025 and bottomed at $365486.0 in Q1 2024.
Historically, Intangibles has averaged $15.5 million across 3 years, with a median of $20.0 million in 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Amgen	206.44 Bn	192.45 Bn	7.24 Bn	20.49 Bn
2	Gilead Sciences	179.97 Bn	176.79 Bn	6.22 Bn	14.03 Bn
3	Vertex Pharmaceuticals	130.57 Bn	122.72 Bn	2.84 Bn	412.80 Mn
4	Regeneron Pharmaceuticals	81.63 Bn	73.63 Bn	3.93 Bn	1.31 Bn
5	Argenx Se	60.34 Bn	55.16 Bn	1.37 Bn	266.00 Mn
6	Moderna	54.37 Bn	49.23 Bn	52.00 Mn	-
7	Alnylam Pharmaceuticals	33.07 Bn	29.76 Bn	992.69 Mn	-
8	Biogen	31.84 Bn	30.55 Bn	1.96 Bn	13.52 Bn
9	Roivant Sciences	29.49 Bn	29.49 Bn	1.16 Mn	-
10	GridAI Technologies	19.07 Mn	19.07 Mn	-36,514.00	20.69 Mn

Historic Data

Download Data